Basic Information
RNALocate ID: | RLID:11001508 |
RNA Symbol: | hsa-miR-214-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-214-3p |
RNA ID: | miRBase:MIMAT0000271 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001658 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001659 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001660 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:11001505 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
RLID:11001506 | Exosome | Plasma | 19289371 |
RLID:11001507 | Exosome | Brain tissue | 23382797 |
RLID:11001509 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000332 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001171 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-214-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-29054 |
MNDR | hsa-miR-214-3p | Oral squamous cell carcinoma | MNDR-E-MI-29055 |
MNDR | hsa-miR-214-3p | Large cell neuroendocrine cancer | MNDR-E-MI-29056 |
MNDR | hsa-miR-214-3p | Medulloblastoma | MNDR-E-MI-29057 |
MNDR | hsa-miR-214-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-29058 |
MNDR | hsa-miR-214-3p | Ovarian clear cell carcinoma | MNDR-E-MI-29059 |
MNDR | hsa-miR-214-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-29060 |
MNDR | hsa-miR-214-3p | Lymphoma | MNDR-E-MI-29061 |
MNDR | hsa-miR-214-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-29062 |
MNDR | hsa-miR-214-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-29063 |
MNDR | hsa-miR-214-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-29064 |
MNDR | hsa-miR-214-3p | Triple negative breast cancer | MNDR-E-MI-29065 |
MNDR | hsa-miR-214-3p | Myeloid neoplasm | MNDR-E-MI-29066 |
MNDR | hsa-miR-214-3p | Dermatomyositis | MNDR-E-MI-29067 |
MNDR | hsa-miR-214-3p | Prostate cancer | MNDR-E-MI-29068 |
MNDR | hsa-miR-214-3p | Gastric cancer | MNDR-E-MI-29069 |
MNDR | hsa-miR-214-3p | Alzheimer disease | MNDR-E-MI-29070 |
MNDR | hsa-miR-214-3p | Bladder cancer | MNDR-E-MI-29071 |
MNDR | hsa-miR-214-3p | Sarcoma | MNDR-E-MI-29072 |
MNDR | hsa-miR-214-3p | Dysautonomia familial | MNDR-E-MI-29073 |
MNDR | hsa-miR-214-3p | Polycystic ovary syndrome | MNDR-E-MI-29074 |
MNDR | hsa-miR-214-3p | Muscular dystrophy duchenne | MNDR-E-MI-29075 |
MNDR | hsa-miR-214-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-29076 |
MNDR | hsa-miR-214-3p | Head and neck cancer | MNDR-E-MI-29077 |
MNDR | hsa-miR-214-3p | Huntington disease | MNDR-E-MI-29078 |
MNDR | hsa-miR-214-3p | Chorea | MNDR-E-MI-29079 |
MNDR | hsa-miR-214-3p | Cardiovascular disease | MNDR-E-MI-29080 |
MNDR | hsa-miR-214-3p | Lung cancer | MNDR-E-MI-29081 |
MNDR | hsa-miR-214-3p | Parkinson disease | MNDR-E-MI-29082 |
MNDR | hsa-miR-214-3p | Breast cancer | MNDR-E-MI-29083 |
MNDR | hsa-miR-214-3p | Squamous cell carcinoma | MNDR-E-MI-29084 |
MNDR | hsa-miR-214-3p | Vascular diseases | MNDR-E-MI-29085 |
MNDR | hsa-miR-214-3p | Pituitary neoplasms | MNDR-E-MI-29086 |
MNDR | hsa-miR-214-3p | Pancreatic cancer | MNDR-E-MI-29087 |
MNDR | hsa-miR-214-3p | Melanoma | MNDR-E-MI-29088 |
MNDR | hsa-miR-214-3p | Rectum adenocarcinoma | MNDR-E-MI-29089 |
MNDR | hsa-miR-214-3p | Nephroblastoma | MNDR-E-MI-29090 |
MNDR | hsa-miR-214-3p | Colon cancer | MNDR-E-MI-29091 |
MNDR | hsa-miR-214-3p | Ischemic attack transient | MNDR-E-MI-29092 |
MNDR | hsa-miR-214-3p | Colon adenocarcinoma | MNDR-E-MI-29093 |
MNDR | hsa-miR-214-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-29094 |
MNDR | hsa-miR-214-3p | Ovarian cancer | MNDR-E-MI-29095 |
MNDR | hsa-miR-214-3p | Kidney cancer | MNDR-E-MI-29096 |
MNDR | hsa-miR-214-3p | Carcinoma ductal breast | MNDR-E-MI-29097 |
MNDR | hsa-miR-214-3p | Glioblastoma | MNDR-E-MI-29098 |
MNDR | hsa-miR-214-3p | Glioma | MNDR-E-MI-29099 |
MNDR | hsa-miR-214-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-29100 |
MNDR | hsa-miR-214-3p | Nemaline myopathy | MNDR-E-MI-29101 |
MNDR | hsa-miR-214-3p | Central nervous system lymphoma | MNDR-E-MI-29102 |
MNDR | hsa-miR-214-3p | Rhabdomyosarcoma | MNDR-E-MI-29103 |
MNDR | hsa-miR-214-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-29104 |
MNDR | hsa-miR-214-3p | Epilepsy temporal lobe | MNDR-E-MI-29105 |
MNDR | hsa-miR-214-3p | Osteosarcoma | MNDR-E-MI-29106 |
MNDR | hsa-miR-214-3p | Liposarcoma | MNDR-E-MI-29107 |
MNDR | hsa-miR-214-3p | Coronary artery disease | MNDR-E-MI-29108 |
MNDR | hsa-miR-214-3p | Inclusion body myositis | MNDR-E-MI-29109 |
MNDR | hsa-miR-214-3p | Gastric adenocarcinoma | MNDR-E-MI-29110 |
MNDR | hsa-miR-214-3p | Pituitary adenoma | MNDR-E-MI-29111 |
MNDR | hsa-miR-214-3p | Non-small cell lung cancer | MNDR-E-MI-29112 |
MNDR | hsa-miR-214-3p | Lung adenocarcinoma | MNDR-E-MI-29113 |
MNDR | hsa-miR-214-3p | Adrenocortical cancer | MNDR-E-MI-29114 |
MNDR | hsa-miR-214-3p | Thyroid carcinoma | MNDR-E-MI-29115 |
MNDR | hsa-miR-214-3p | Ovarian carcinoma | MNDR-E-MI-29116 |
MNDR | hsa-miR-214-3p | Bladder urothelial carcinoma | MNDR-E-MI-29117 |
MNDR | hsa-miR-214-3p | Pancreatic adenocarcinoma | MNDR-E-MI-29118 |
MNDR | hsa-miR-214-3p | Scleroderma | MNDR-E-MI-29119 |
MNDR | hsa-miR-214-3p | Cervical cancer | MNDR-E-MI-29120 |
MNDR | hsa-miR-214-3p | Carcinoma renal cell | MNDR-E-MI-29121 |
MNDR | hsa-miR-214-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-29122 |
MNDR | hsa-miR-214-3p | Clear cell renal cell carcinoma | MNDR-E-MI-29123 |
MNDR | hsa-miR-214-3p | Chromophobe renal cell carcinoma | MNDR-E-MI-29124 |
MNDR | hsa-miR-214-3p | Pancreatic carcinoma | MNDR-E-MI-29125 |
MNDR | hsa-miR-214-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-29126 |
MNDR | hsa-miR-214-3p | Cholangiocarcinoma | MNDR-E-MI-29127 |
MNDR | hsa-miR-214-3p | Esophageal cancer | MNDR-E-MI-29128 |
MNDR | hsa-miR-214-3p | Oncocytoma | MNDR-E-MI-29129 |
MNDR | hsa-miR-214-3p | Lung small cell carcinoma | MNDR-E-MI-29130 |
MNDR | hsa-miR-214-3p | Synovial sarcoma | MNDR-E-MI-29131 |
MNDR | hsa-miR-214-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-29132 |
MNDR | hsa-miR-214-3p | Heart failure | MNDR-E-MI-29133 |
MNDR | hsa-miR-214-3p | Pulmonary hypertension | MNDR-E-MI-29134 |
MNDR | hsa-miR-214-3p | Adenoma | MNDR-E-MI-29135 |
MNDR | hsa-miR-214-3p | Breast invasive carcinoma | MNDR-E-MI-29136 |
MNDR | hsa-miR-214-3p | Hepatocellular carcinoma | MNDR-E-MI-29137 |
MNDR | hsa-miR-214-3p | Embryonal cancer | MNDR-E-MI-29138 |
MNDR | hsa-miR-214-3p | B-cell lymphoma | MNDR-E-MI-29139 |
MNDR | hsa-miR-214-3p | Neuroblastoma | MNDR-E-MI-29140 |
MNDR | hsa-miR-214-3p | Periodontitis | MNDR-E-MI-29141 |
MNDR | hsa-miR-214-3p | Hodgkin lymphoma | MNDR-E-MI-29142 |
MNDR | hsa-miR-214-3p | Ulcerative colitis | MNDR-E-MI-29143 |
MNDR | hsa-miR-214-3p | Burkitt lymphoma | MNDR-E-MI-29144 |
MNDR | hsa-miR-214-3p | Tonsil cancer | MNDR-E-MI-29145 |
MNDR | hsa-miR-214-3p | Colorectal cancer | MNDR-E-MI-29146 |
MNDR | hsa-miR-214-3p | Multiple myeloma | MNDR-E-MI-29147 |
MNDR | hsa-miR-214-3p | Nasopharyngeal disease | MNDR-E-MI-29148 |
MNDR | hsa-miR-214-3p | Uterine cervical neoplasms | MNDR-E-MI-29149 |
MNDR | hsa-miR-214-3p | Cardiomegaly | MNDR-E-MI-29150 |
MNDR | hsa-miR-214-3p | Nasopharyngeal cancer | MNDR-E-MI-29151 |
MNDR | hsa-miR-214-3p | Prostatic neoplasms | MNDR-E-MI-29152 |
MNDR | hsa-miR-214-3p | Lymphoma t-cell | MNDR-E-MI-29153 |
MNDR | hsa-miR-214-3p | Polymyositis | MNDR-E-MI-29154 |
MNDR | hsa-miR-214-3p | Stroke lacunar | MNDR-E-MI-29155 |
MNDR | hsa-miR-214-3p | Breast cancer her3+ negative | MNDR-E-MI-29156 |
MNDR | hsa-miR-214-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-29157 |
MNDR | hsa-miR-214-3p | Tubulovillous adenoma | MNDR-E-MI-29158 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AIFM2 | Homo sapiens | RR00059432 |
TOP